or Try an Advanced Search...

    Depressive Disorder Stocks List

    Symbol Grade Name % Change
    LLY A Eli Lilly and Company 1.83
    ABBV C AbbVie Inc. 2.08
    ITCI C Intra-Cellular Therapies Inc. 0.71
    PFE C Pfizer, Inc. 1.26
    AZN C Astrazeneca PLC 0.70
    VNDA C Vanda Pharmaceuticals Inc. -2.24
    BWAY C Brainsway Ltd. -2.19
    ALKS C Alkermes plc 0.25
    PRAX D Praxis Precision Medicines, Inc. 0.80
    NERV D Minerva Neurosciences, Inc -1.27
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Major Depressive Disorder Biopharmaceutical Neuroscience Schizophrenia Treatment Of Major Depressive Disorder Hypertension Insomnia Mental Health Alcohol Alzheimer's Disease Angina Antidepressants Bipolar Disorder Central Nervous System Disorders Chemotherapy Cholesterol Clinic Clinical Development Depression Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Depressive Disorder stocks.

    Symbol Grade Name Weight
    IHE B iShares U.S. Pharmaceutical ETF 35.32
    MEDX B Horizon Kinetics Medical ETF 30.61
    PPH B Market Vectors Pharmaceutical ETF 26.94
    OZEM B Roundhill GLP-1 & Weight Loss ETF 21.39
    THNR B Amplify Weight Loss Drug & Treatment ETF 20.9
    View all Depressive Disorder ETFs...
    Compare ETFs
    Compare IHE to MEDX Compare IHE to THNR Compare PPH to THNR

        Depressive Disorder Stocks Recent News

        Date Stock Title
        Jul 5 PFE Executive reshuffles: NIO, Pfizer and Spirit Airlines in focus
        Jul 5 AZN AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
        Jul 5 LLY Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
        Jul 5 PFE Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
        Jul 5 AZN AstraZeneca’s Tagrisso plus chemotherapy wins EU approval for NSCLC
        Jul 5 AZN AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
        Jul 5 LLY Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 AZN Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
        Jul 5 LLY Eli Lilly Remains an Equities Outlier
        Jul 5 PFE Pfizer names former State Street CEO Taraporevala to board
        Jul 5 AZN Investors in AstraZeneca (LON:AZN) have seen strong returns of 115% over the past five years
        Jul 5 AZN What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
        Jul 5 LLY Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio
        Jul 5 PFE 3 Dividend Stocks That Are Screaming Buys in July
        Jul 4 LLY Here's How Much $100 Invested In Eli Lilly and Co 15 Years Ago Would Be Worth Today
        Jul 4 ABBV AbbVie Q2 Preview: Upgrade To Buy - Better Late Than Never
        Jul 4 LLY NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
        Jul 4 LLY Mounjaro and Zepbound Are Great, but This Is the Real Reason Why Eli Lilly Can Soar Past a $1 Trillion Valuation
        Jul 4 PFE Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 68% of the company
        Jul 4 LLY FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Major Depressive Disorder Neuroscience Biopharmaceutical Schizophrenia Treatment Of Major Depressive Disorder Hypertension Mental Health Alzheimer's Disease Bipolar Disorder Depression Dysfunction Insomnia Pharmaceutical Products Psychiatry S&P 500 Animal Health Antidepressants Central Nervous System Disorders Cholesterol Clinic
        Depressive Disorder

        Depressive disorder, also known as major depressive disorder or clinical depression, is a mental health condition characterized by persistent feelings of sadness, hopelessness, and worthlessness. Symptoms can include changes in sleep, appetite, energy levels, concentration, and self-esteem. People with depressive disorder may also experience physical symptoms such as headaches, digestive problems, and chronic pain. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes.

        Browse All Tags